Maxcyte, Inc.
MXCT- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001287098
No open-market purchases or sales by Maxcyte, Inc. insiders were filed in the last 90 days; 122 institutions reported holding it in 13F filings for Q2 2026, worth $78.0M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Maxcyte, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Of which not filed for Q3 2025 | Q3 2025 | Change |
|---|---|---|---|---|
| Holders | 120 | 1 | 112 | −7 |
| Shares | 71.4M | 12.5K | 70.1M | −1.27M (−1.8%) |
| Value | $155.5M | $27.2K | $110.8M | −$44.7M (−28.8%) |
1 institution that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (17)
Institutions that held Maxcyte, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| AXA Investment Managers S.A. | 2,773,554 | $4.38M | 0.01% |
| Kennedy Capital Management, Inc. | 2,107,392 | $3.33M | 0.07% |
| Stonepine Capital Management, LLC | 459,018 | $725.2K | 0.59% |
| Point72 Asset Management, L.P. | 378,039 | $597.3K | 0.00% |
| Luminus Management LLC | 225,000 | $355.5K | 0.32% |
| Warren Averett Asset Management, LLC | 50,266 | $79.4K | 0.00% |
| Cerity Partners LLC | 30,672 | $48.5K | 0.00% |
| Graham Capital Management, L.P. | 26,406 | $41.7K | 0.00% |
| Qube Research & Technologies Ltd | 12,897 | $20.4K | 0.00% |
| CIBC Bancorp USA Inc. | 10,779 | $17.0K | 0.00% |
| Russell Investments Group, Ltd. | 9,484 | $15.0K | 0.00% |
| Cubist Systematic Strategies, LLC | 3,225 | $5.09K | 0.00% |
| Point72 (DIFC) Ltd | 2,348 | $3.71K | 0.00% |
| SRS Capital Advisors, Inc. | 2,121 | $3.35K | 0.00% |
| Steward Partners Investment Advisory, LLC | 168 | $265 | 0.00% |
| Clearstead Advisors, LLC | 97 | $154 | 0.00% |
| Transamerica Financial Advisors, Inc. | 94 | $149 | 0.00% |
Sold out (24)
Institutions that held Maxcyte, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| AXA S.A. | 2,202,378 | $4.80M |
| Silvercrest Asset Management Group LLC | 1,074,631 | $2.34M |
| Royce & Associates LP | 657,080 | $1.43M |
| Rice Hall James & Associates, LLC | 417,846 | $910.9K |
| Lazard Asset Management LLC | 284,498 | $620.0K |
| Bleichroeder LP | 250,000 | $521.9K |
| Schroder Investment Management Group | 136,947 | $298.5K |
| EntryPoint Capital, LLC | 61,280 | $133.6K |
| Sanctuary Advisors, LLC | 50,116 | $109.3K |
| HRT Financial LP | 37,497 | $81.0K |
| State Board of Administration of Florida Retirement System | 25,080 | $54.7K |
| Squarepoint Ops LLC | 22,999 | $50.1K |
| Dynamic Technology Lab Private Ltd | 18,222 | $40.0K |
| Envestnet Asset Management Inc | 12,845 | $28.0K |
| May Hill Capital, LLC | 12,382 | $27.0K |
| Zacks Investment Management | 11,976 | $26.1K |
| R Squared Ltd | 10,300 | $22.5K |
| Ridgewood Investments LLC | 1,000 | $2.18K |
| Fortitude Family Office, LLC | 693 | $1.51K |
| Raymond James Financial Inc | 303 | $661 |
| Allworth Financial LP | 71 | $155 |
| Simplex Trading, LLC | 100 | $0 |
| Covestor Ltd | 5 | $0 |
| Bank of Montreal | 341 | – |
Not filed for Q3 2025 yet (1)
Institutions that held Maxcyte, Inc. at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| CIBC World Markets Corp | 12,460 | $27.2K |